Results 251 to 260 of about 159,323 (346)

A Case of Amyloid Light-Chain Amyloidosis Presenting as Colitis. [PDF]

Cureus
Prabakaran K, Khan S, Mei L, Edeani F, Sanvanson P, Sivasubramaniam P, Ali M, Balasubramanian G.   +7 more
europepmc   +1 more source

Stabilizing Extreme Few‐Shot ECG Classification via Self‐Supervised Contrastive Pretraining

Annals of Noninvasive Electrocardiology, Volume 31, Issue 3, May 2026.
Under extreme few‐shot ECG classification, supervised training frequently collapses to degenerate solutions. Self‐supervised pretraining stabilizes optimization, eliminates early collapse, and enables reproducible multi‐class rhythm classification with limited labeled data. ABSTRACT In clinical electrocardiogram (ECG) analysis, high‐quality annotations
LiuPing Zeng, JingMei Pan, YangJie Lu, Xian Pan   +3 more
wiley   +1 more source

Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis. [PDF]

Anal Chem
Greco F, McPhail E, Canetti D, Masri A, Ferrari Chen YF, Menichetti L, Aimo A, Franzini M, Ciccone L, Pucci A, Castiglione V, Limongelli G, Merlo M, Sinagra G, Basso C, Fontana M, Gillmore JD, McDonnell LA, Emdin M, Merlini G, Vergaro G.   +20 more
europepmc   +1 more source

Meta‐Analysis: Prevalence and Incidence of Gastroparesis Following Lung or Heart Transplantation

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 10, Page 1348-1359, May 2026.
Gastroparesis occurs in nearly one‐third of lung and heart‐lung transplant recipients (pooled prevalence 31.9%; incidence 25.7%), driven by surgical complexity, perioperative opioid exposure, and diagnostic criteria. Standardized gastric emptying assessment and multidisciplinary management, including opioid minimization, immunosuppressant optimization,
Mohamed H. Eldesouki, Mohamed Mahmoud Marey, Mohamed Ahmed Ali, Amany Mahmoud Genidy, Mohamed Hesham Gamal, Ali M. Othman, Ahmed N. Mohamed, Ahmed Al Qady, Manuel A. Amaris, Amol Sharma   +9 more
wiley   +1 more source

The impact of cardiac amyloidosis on patients with multiple myeloma: a systematic review and meta-analysis. [PDF]

Cardiooncology
Novo G, Stabile F, Di Lisi D, Madaudo C, Jaramillo S, Damiani F, Orilia C, Camilli M, Buccheri S, van Der Meer P, Galassi AR, Lyon AR.   +11 more
europepmc   +1 more source

Optimizing Oligonucleotide Therapeutics: A Model‐Informed Drug Development Perspective

Clinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT Oligonucleotide therapies have emerged as a powerful therapeutic class, providing novel solutions for diverse diseases through antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and aptamers that specifically target and modulate gene expression or protein function. However, oligonucleotide development faces distinct challenges,
Ye Yuan, Vishnu Sharma, Venkatesh Atul Bhattaram, Xiaolei Pan, Justin Earp, Yun Wang, Jiang Liu, Hao Zhu   +7 more
wiley   +1 more source

Patient with AL amyloidosis with recurrent syncope as the first symptom: case report and literature review. [PDF]

Front Oncol
Hu L, Luo L, Yao N, Mi J, Zhang Y, Sun M, Wang H, Xu Y, Wang W, Hu J, Lu H.   +10 more
europepmc   +1 more source

Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis‐Requiring Severe Renal Impairment

European Journal of Haematology, Volume 116, Issue 5, Page 577-584, May 2026.
ABSTRACT Background Severe renal insufficiency requiring dialysis in newly diagnosed multiple myeloma (NDMM) patients has been independently associated with poor survival outcomes. However, there is a paucity of data on factors predicting renal recovery and survival outcomes of these patients.
Rintu Sharma, Eshetu G. Atenafu, Esther Masih‐Khan, Harjot Vohra, Sita Bhella, Christine Chen, Vishal Kukreti, Guido Lancman, Anca Prica, A. Keith Stewart, Rodger Tiedemann, Suzanne Trudel, Chloe Yang, Donna Reece   +13 more
wiley   +1 more source

Leukocyte Chemotactic Factor 2 Amyloidosis (LECT-2) Amyloidosis Case Report and Review of the Current Literature. [PDF]

Clin Case Rep
Matarneh AS, Matarneh B, Salameh OK, Sardar S, Abendroth C, Ghahramani N, Verma N.   +6 more
europepmc   +1 more source